Drug Type Small molecule drug |
Synonyms PIVYA, Pivmecillinam, Pivmecillinam Hydrochloride + [6] |
Target |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date DK (10 Sep 2014), |
RegulationQualified Infectious Disease Product (US), Priority Review (US) |
Molecular FormulaC21H34ClN3O5S |
InChIKeyUHPXMYLONAGUPC-WKLLBTDKSA-N |
CAS Registry32887-03-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01499 | AMDINOCILLIN PIVOXIL |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Urinary Tract Infections | US | UTILITY therapeutics Ltd.Startup | 24 Apr 2024 |
Cystitis | DK | 10 Sep 2014 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystitis | Phase 3 | CN | 29 Sep 2022 | |
Salmonella Infections | Discovery | CN | 20 Mar 2021 | |
Urinary Tract Infections | Discovery | CN | 20 Mar 2021 |
FDA_CDER Manual | Not Applicable | 282 | (hmyccehyoa) = okluvtwcgv fukarysllg (zxwlslecml ) View more | Positive | 24 Apr 2024 | ||
FDA_CDER Manual | Not Applicable | 84 | (olohvnzvvl) = azldatesqx uxwzabuziu (ofalqriknr ) | Positive | 24 Apr 2024 | ||
FDA_CDER Manual | Not Applicable | 259 | (zpmkbgbeds) = rbccvxwnuw xiuikzywjs (fkurfeyfft ) View more | Positive | 24 Apr 2024 | ||
(zpmkbgbeds) = fxhzjxffas xiuikzywjs (fkurfeyfft ) View more | |||||||
NCT01849926 (FDA_CDER) Manual | Phase 3 | 224 | (lkmgjookpm) = zdovelpmsu szyyleihhq (skvynvjxlh ) View more | Positive | 24 Apr 2024 | ||
(lkmgjookpm) = pcmpubrkka szyyleihhq (skvynvjxlh ) View more |